• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains

    Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality

    Nutrition and Flavor: Formulating for Modern Product Preferences

    What Do Consumers Know About the Gut Microbiome?

    How Will the European Green Deal Impact Dietary Supplements?
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Monk Fruit Sweetener May Have Prebiotic Activity, Study Finds

    People with Low-Fiber Diets Benefit the Most from Fiber Supplements, Study Finds

    BAPP Publishes Lab Guidance Document on Indian Frankincense (Boswellia serrata)

    Chenland Nutritionals Self-Affirms GRAS for Cumin UP60 Ingredient

    Gut Microbiome May Be Part of Link Between Red Meat and Heart Disease Risk
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Monk Fruit Sweetener May Have Prebiotic Activity, Study Finds

    People with Low-Fiber Diets Benefit the Most from Fiber Supplements, Study Finds

    BAPP Publishes Lab Guidance Document on Indian Frankincense (Boswellia serrata)

    Chenland Nutritionals Self-Affirms GRAS for Cumin UP60 Ingredient

    Food Processing for Health and Wellness
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Monk Fruit Sweetener May Have Prebiotic Activity, Study Finds

    People with Low-Fiber Diets Benefit the Most from Fiber Supplements, Study Finds

    BAPP Publishes Lab Guidance Document on Indian Frankincense (Boswellia serrata)

    Chenland Nutritionals Self-Affirms GRAS for Cumin UP60 Ingredient

    Gut Microbiome May Be Part of Link Between Red Meat and Heart Disease Risk
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Monk Fruit Sweetener May Have Prebiotic Activity, Study Finds

    People with Low-Fiber Diets Benefit the Most from Fiber Supplements, Study Finds

    Gut Microbiome May Be Part of Link Between Red Meat and Heart Disease Risk

    Nutritional Growth Solutions’ Healthy Heights Enters South Korea Market

    Flower Pollen Extract Benefits Women’s Urinary Incontinence, Study Finds
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Nutrition21, LLC

    Atlantia Clinical Trials

    Bioenergy Life Science, Inc. (BLS)

    JRS Pharma

    Xsto Solutions
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Nutrition21, LLC

    Atlantia Clinical Trials

    Bioenergy Life Science, Inc. (BLS)

    JRS Pharma

    Xsto Solutions
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Research Expands on Use of Curcumin C3 Complex as Adjunct to Chemotherapy

    Study authors conclude combination of curcumin with FOLFOX chemotherapy represents a safe and tolerable treatment and a phase III trial is warranted.

    Related CONTENT
    • Sabinsa Self-Affirms GRAS Status of Curcumin C3 Reduct
    • Publication Provides Comprehensive Overview of Curcumin Research
    • Targeted Health Solutions for Every Life-Stage
    • Turmeric & Curcumin: Rising Stars of the Nutrition World
    • Sabinsa Obtains Patents for ForsLean Coleus Forskohlii Extract Related to Energy Balance
    06.24.19
    Sabinsa’s Curcumin C3 Complex has been studied as an adjuvant therapy with several cancer drugs in the past, and the body of science continues to grow with the recent publication of more positive research.  
     
    In continuation of two earlier related studies, researchers at the University of Leicester in the U.K. published the results of a phase IIa, open-labeled trial in which 27 subjects with metastatic colorectal cancer were randomized to take FOLFOX or FOLFOX + Curcumin C3 Complex (CUFOX). The study was directed toward the evaluation of safety, and efficacy of treatment via progression-free survival and overall survival. In general, CUFOX was well tolerated by all the subjects. Where causality was reported as possibly or probably related to curcumin were primarily gastrointestinal in nature, with the most common being diarrhea. In the per-protocol group median progression-free survival was 171 days for FOLFOX and 320 days for CUFOX. Median overall survival was 200 days for FOLFOX and 596 days for CUFOX. This is the first randomized controlled trial of CUFOX in metastatic colorectal subjects which has shown the safety and tolerability of CUFOX in subjects.
     
    The authors conclude that “…combination of curcumin with FOLFOX chemotherapy represents a safe and tolerable treatment with potential to provide patient benefit,” and that a phase III trial is warranted.
     
    “Research examining the use of drugs and nutraceuticals together is an exciting new direction to investigate,” said N. Kalyanam, PhD, Sabinsa’s president of R&D. “Sabinsa continues to build on science and contribute to the extensive knowledge base of curcumin for better health for all.”
     
    The study, Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial, was published in the Journal of Nutrition: doi/10.1093/jn/nxz029/5499032.
     
    The study protocol, combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomized control trial, was previously published in Trials 2015 and can be accessed here:  doi.org/10.1186/s13063-015-0641-1.
     
    A previous research article on a two-part study, Curcumin  inhibits  cancer  stem  cell  phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy, was published in Cancer Letters in  2015 (doi:  10.1016/j.canlet.2015.05.005). The first part of the study included an ex vivo model to test the efficacy of the curcumin and FOLFOX therapy on cancer liver metastases. The second part included a phase I dose escalation study, which evaluated the safety and tolerability of curcumin during FOLFOX chemotherapy. Overall, the study results indicated that the combination of curcumin and 5-FU/oxaliplatin reduced the number of spheroids and downregulated cancer stem cells markers such as CD44, CD166, and ALDH activity. In the phase I dose escalation study, curcumin was found to be safe and tolerable up to a dose of 2 g in the colorectal cancer with liver metastases subjects.
     
     
    Related Searches
    • Research
    • sabinsa
    • Nutrition
    • Health
    Related Knowledge Center
    • Herbs & Botanicals
    • Antioxidants
    • Cancer Risk
    Suggested For You
    Sabinsa Self-Affirms GRAS Status of Curcumin C3 Reduct Sabinsa Self-Affirms GRAS Status of Curcumin C3 Reduct
    Publication Provides Comprehensive Overview of Curcumin Research Publication Provides Comprehensive Overview of Curcumin Research
    Targeted Health Solutions for Every Life-Stage Targeted Health Solutions for Every Life-Stage
    Turmeric & Curcumin: Rising Stars of the Nutrition World Turmeric & Curcumin: Rising Stars of the Nutrition World
    Sabinsa Obtains Patents for ForsLean Coleus Forskohlii Extract Related to Energy Balance Sabinsa Obtains Patents for ForsLean Coleus Forskohlii Extract Related to Energy Balance
    Excellence in Research and Manufacturing Excellence in Research and Manufacturing
    Sabinsa Appoints Lori Diez Sales Manager- Texas Sabinsa Appoints Lori Diez Sales Manager- Texas
    Seaweed Extract’s Anti-Cancer Pathways Revealed through In Vitro Study Seaweed Extract’s Anti-Cancer Pathways Revealed through In Vitro Study
    Kemin Receives GRAS Approval for Oil-Soluble Green Tea Extract Kemin Receives GRAS Approval for Oil-Soluble Green Tea Extract
    Sabinsa Shagandha Ashwagandha Root Extract 2.5% Meets USP Monograph Sabinsa Shagandha Ashwagandha Root Extract 2.5% Meets USP Monograph
    Nano-Encapsulation Technology Could Enhance Absorption of Omega-3 DHA Nano-Encapsulation Technology Could Enhance Absorption of Omega-3 DHA
    Delta-Tocotrienol Combined with Standard Therapy May Increase Survival in Ovarian Cancer Patients Delta-Tocotrienol Combined with Standard Therapy May Increase Survival in Ovarian Cancer Patients
    Large Meta-Analysis Backs Benefits of Probiotic for Gut Health Large Meta-Analysis Backs Benefits of Probiotic for Gut Health
    10% of U.S. Adults Have Food Allergy; Nearly 20% Think They Do 10% of U.S. Adults Have Food Allergy; Nearly 20% Think They Do
    Study Finds Mixture of Probiotic Strains and Lactoferrin Reduces Common Cause of Vaginal Discomfort Study Finds Mixture of Probiotic Strains and Lactoferrin Reduces Common Cause of Vaginal Discomfort

    Related Breaking News

    • Breaking News | Herbs & Botanicals | Supplier News

      Sabinsa Self-Affirms GRAS Status of Curcumin C3 Reduct

      Patented turmeric extract deemed safe for use in foods and beverages.
      06.03.19

    • Breaking News | Herbs & Botanicals | Research | Supplier News
      Publication Provides Comprehensive Overview of Curcumin Research

      Publication Provides Comprehensive Overview of Curcumin Research

      Sabinsa’s Curcumin C3 Complex identified as the most studied form.
      05.03.19

    • Antioxidants | Bone & Joint Health | Cardiovascular Health | Cognitive Function | Consumer Trends | Diabetes & Blood Sugar Management | Dietary Supplements | Digestive Health | Eye Health | Fatty Acids | Healthcare Trends | Healthy Aging | Herbs & Botanicals | Immune Function | Inflammation | Minerals | Omega-3s | Probiotics & Prebiotics | Proteins, Peptides, Amino Acids | Skin Health | Sports Nutrition | Vitamins | Weight Management/Weight Loss
      Targeted Health Solutions for Every Life-Stage

      Targeted Health Solutions for Every Life-Stage

      Dedication to optimizing health among consumers of all ages has opened limitless opportunities for wellness brands.
      By Sean Moloughney, Editor 05.02.19


    • Bone & Joint Health | Cardiovascular Health | Consumer Trends | Diabetes & Blood Sugar Management | Functional Foods & Beverages | Herbs & Botanicals | Mood Health & Sleep | Research | Sports Nutrition
      Turmeric & Curcumin: Rising Stars of the Nutrition World

      Turmeric & Curcumin: Rising Stars of the Nutrition World

      As consumers clamor for these potent compounds, manufacturers and suppliers must deliver high-quality products.
      By Nutraceuticals World Staff 05.02.19

    • Breaking News | Certifications, Approvals & Patents | Energy | Herbs & Botanicals | Supplier News | Weight Management/Weight Loss
      Sabinsa Obtains Patents for ForsLean Coleus Forskohlii Extract Related to Energy Balance

      Sabinsa Obtains Patents for ForsLean Coleus Forskohlii Extract Related to Energy Balance

      Scientific discovery shows Forskolin aids in fat conversion into heat.
      04.04.19

    Loading, Please Wait..
    Trending
    • First Day Life Shuts Down Children's Behavioral, Cognitive Health Claims Following Challenge
    • Study Examines Vitamin K2 Content In Cheese
    • Chenland Nutritionals Self-Affirms GRAS For Cumin UP60 Ingredient
    • Pycnogenol Evidenced To Have Skin Benefits In Dermatology Study
    Breaking News
    • Monk Fruit Sweetener May Have Prebiotic Activity, Study Finds
    • People with Low-Fiber Diets Benefit the Most from Fiber Supplements, Study Finds
    • BAPP Publishes Lab Guidance Document on Indian Frankincense (Boswellia serrata)
    • Chenland Nutritionals Self-Affirms GRAS for Cumin UP60 Ingredient
    • Gut Microbiome May Be Part of Link Between Red Meat and Heart Disease Risk
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • A Growing Herbal Products Market Still Faces Formidable Threats, Challenges
    • Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality
    • Nutrition and Flavor: Formulating for Modern Product Preferences
    • Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains
    • How Will the European Green Deal Impact Dietary Supplements?
    • What Do Consumers Know About the Gut Microbiome?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Monk Fruit Sweetener May Have Prebiotic Activity, Study Finds
    People with Low-Fiber Diets Benefit the Most from Fiber Supplements, Study Finds
    BAPP Publishes Lab Guidance Document on Indian Frankincense (Boswellia serrata)
    Coatings World

    Latest Breaking News From Coatings World

    Tnemec Announces New Senior Manager of Performance Coatings
    Shortlist Announced for British Coatings Federation’s 2022 Awards
    Chemours Details Progress in its Fifth Corporate Responsibility Commitment Report
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Study Projects Steep Rise in Cardiovascular Diseases by 2060
    Bot Image's ProstatID AI Software Gains FDA Nod
    Researchers Develop Deep Learning Model for Eye Disorder Screening
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sartorius Stedim Biotech Agrees to Acquire Albumedix
    MilliporeSigma to Provide Full Viral Vector Offering with Launch of VirusExpress 293
    Charles River Receives EMA Approval to Produce Allogeneic Cell Therapy
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    NJPEC Announces 2022 Package of the Year Awards
    Tree Hut Introduces New Sugar Scrubs
    Fashion Designer Issey Miyake Dies
    Happi

    Latest Breaking News From Happi

    Kayali Releases Lovefest Burning Cherry, a New Fragrance from Mona Kattan
    Estée Lauder To Have EV Car Fleet by 2030
    Core Revenue for Amyris, Inc. Grows 54% in Q2
    Ink World

    Latest Breaking News From Ink World

    Shortlist Announced for the British Coatings Federation’s 2022 Awards
    Ecuadorian Seed Association Opts for SICPA Technology
    ACTEGA to Launch New Products at Labelexpo Americas
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    UPM Raflatac bringing multi-sensory experience to Labelexpo Americas
    Meyers turns to Domino for label, folding carton jobs
    ACTEGA to launch new products at Labelexpo Americas
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity Switches to Recyclable Packs for Feminine Pads
    Huntsman to Sell Textile Effects Business to Archoma
    FTC Sues PPE Maker on False Origin Claims
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Stratasys to Buy Covestro's 3D Printing Materials Biz for €43M
    NeuroOne Submits Special 510(k) to FDA for sEEG Electrode
    Custom 3D-Printed Titanium Lower Jaw Used in First Successful Surgery
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    STMicroelectronics Launches Multi-cCnnectivity Development Kit
    Emerson to Sell InSinkErator Business to Whirlpool Corporation for $3 Billion
    CdTe Accelerator Consortium Aims to Reduce Costs, Speed Deployment

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login